EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

High frequency of CD95 + / CD45RA − regulatory T cells defines an immunosuppressive profile associated with MDS progression

Romain Vazquez, Nicolas Deredec, Ismael Boussaid, Pierre Boncoeur, Camille Knosp, Amandine Houvert, Loria Zalmai, Chloe Friedrich, Carole Almire, Charles Dussiau, Lise Willems, Rudy Birsen und 7 weitere

British Journal of Haematology · 2026-06 · 208 (6) · 1993-2003

DOI: 10.1111/bjh.70504 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 04.05.2026. Verfasst von Romain Vazquez und 18 weiteren Autor:innen. Beteiligte Einrichtung: Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Biologique, Hôpital Cochin, Paris, France. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Myelodysplastic Syndromes, Leukocyte Common Antigens, fas Receptor. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fondation pour la Recherche Médicale, French National Research Agency, Agence Nationale de la Recherche.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dynamic interactions between mutated haematopoietic cells and immune cells are key drivers of myelodysplastic neoplasms (MDS) initiation and progression. Regulatory T cells (Tregs) are central mediators of immunosuppression in MDS. We thus aimed to characterize Treg subpopulations in the bone marrow (BM) of MDS patients and to explore their clinical significance. Using mass cytometry and an unbiased multidimensional analytical approach, we first confirmed the presence in MDS BM of two Treg subsets, including the highly activated CD95 + /CD45RA − subpopulation previously reported in aplastic anaemia. We then prospectively analysed Tregs distribution in BM of 113 MDS patients at diagnosis and during follow‐up. While Treg proportions among CD4 + T cells were unchanged, CD95 + /CD45RA − Tregs were significantly expanded in the BM of both low‐ and high‐risk MDS patients. CD95 + /CD45RA − Tregs accumulated during disease evolution but remained stable in patients responding to hypomethylating agents. At diagnosis, CD95 + /CD45RA − Tregs levels correlated with specific clinical features: low CD95 + /CD45RA − Tregs with TET2/IDH mutations and autoimmune manifestations; high CD95 + /CD45RA − Tregs with an increased risk of disease progression independently of the IPSS‐R and the IPSS‐M. Our findings suggest that profiling Treg subpopulations at diagnosis could improve MDS risk stratification and guide immunosuppressive therapeutic decisions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

T-Lymphocytes, RegulatoryMyelodysplastic SyndromesLeukocyte Common Antigensfas ReceptorHumansDisease ProgressionFemaleMaleAgedMiddle AgedAged, 80 and overAdultBone MarrowImmune Tolerance

Stichwörter der Autor:innen

myelodysplastic neoplasmsregulatory T cells

Substanzen

Leukocyte Common Antigensfas Receptor

Autor:innen und Institutionen

  • Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Biologique, Hôpital Cochin, Paris, France.
  • Université Paris Cité, Institut Cochin, CNRSUMR8104, INSERM U1016, a Member of OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France.
  • Leukemia Institute Paris Saint-Louis, Paris, France.
  • Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Clinique, Hôpital Cochin, Paris, France.
  • Comprehensive Cancer Centre, King's College, London, UK.
  • International Integrative Innovative Immunology for MDS (i4MDS) Consortium.

ORCID-Profile: Michaela Fontenay, Nicolas Chapuis

Förderung

  • Fondation pour la Recherche Médicale
  • French National Research Agency
  • Agence Nationale de la Recherche

Zitieren

APA

Vazquez, R., Deredec, N., Boussaid, I., Boncoeur, P., Knosp, C., Houvert, A., Zalmai, L., Friedrich, C., Almire, C., Dussiau, C., Willems, L., Birsen, R., Decroocq, J., Bouscary, D., Kosmider, O., Kordasti, S., Fontenay, M., Simoni, Y., & Chapuis, N. (2026). High frequency of CD95 + / CD45RA − regulatory T cells defines an immunosuppressive profile associated with MDS progression. British Journal of Haematology, 208(6), 1993-2003. https://doi.org/10.1111/bjh.70504

Vancouver

Vazquez R, Deredec N, Boussaid I, Boncoeur P, Knosp C, Houvert A, et al. High frequency of CD95 + / CD45RA − regulatory T cells defines an immunosuppressive profile associated with MDS progression. British Journal of Haematology. 2026;208(6):1993-2003. doi:10.1111/bjh.70504

BibTeX
@article{Vazquez2026,
  author = {Vazquez, Romain and Deredec, Nicolas and Boussaid, Ismael and Boncoeur, Pierre and Knosp, Camille and Houvert, Amandine and Zalmai, Loria and Friedrich, Chloe and Almire, Carole and Dussiau, Charles and Willems, Lise and Birsen, Rudy and Decroocq, Justine and Bouscary, Didier and Kosmider, Olivier and Kordasti, Shahram and Fontenay, Michaela and Simoni, Yannick and Chapuis, Nicolas},
  title = {High frequency of CD95 + / CD45RA − regulatory T cells defines an immunosuppressive profile associated with MDS progression},
  journal = {British Journal of Haematology},
  year = {2026},
  volume = {208},
  number = {6},
  pages = {1993--2003},
  doi = {10.1111/bjh.70504}
}
Kostenlos starten →